Mnemo Therapeutics is a Paris-based biotechnology company driven to create powerful immunotherapies by improving the body’s ability to detect and eradicate cancer
Mnemo Therapeutics is a Paris-based biotechnology company driven to create powerful immunotherapies by improving the body’s ability to detect and eradicate cancer. The company has developed a combination of in-silico and wet-lab pipelines to uncover new tumour-specific targets (called E-antigens) and to develop multiple therapeutic modalities targeting these E-antigens.